Difference between revisions of "Αkroprint"
Jump to navigation
Jump to search
WikiModEn2 (talk | contribs) (Add URL.) |
WikiModEn2 (talk | contribs) (Add external link.) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 14: | Line 14: | ||
|accessdate=2025-06-12 | |accessdate=2025-06-12 | ||
}}</ref> | }}</ref> | ||
| + | |||
| + | In the logo, the company writes its name as '''αkroprint'''. | ||
{{SEEALSO}} | {{SEEALSO}} | ||
| Line 19: | Line 21: | ||
{{LINKS}} | {{LINKS}} | ||
| − | |||
* {{URLwebsite|https://www.akroprint.com/|2025-06-12}} | * {{URLwebsite|https://www.akroprint.com/|2025-06-12}} | ||
* {{REFjournal | * {{REFjournal | ||
| Line 36: | Line 37: | ||
|etal=yes | |etal=yes | ||
|title=3D bioprinting for skin tissue engineering: Current status and perspectives | |title=3D bioprinting for skin tissue engineering: Current status and perspectives | ||
| − | |||
| − | |||
|journal=J Tissue Eng | |journal=J Tissue Eng | ||
|date=2021-07-13 | |date=2021-07-13 | ||
|volume=12 | |volume=12 | ||
|article=20417314211028574 | |article=20417314211028574 | ||
| − | |||
| − | |||
|url=https://journals.sagepub.com/doi/10.1177/20417314211028574 | |url=https://journals.sagepub.com/doi/10.1177/20417314211028574 | ||
| − | |||
| − | |||
|pubmedID=34345398 | |pubmedID=34345398 | ||
|pubmedCID=8283073 | |pubmedCID=8283073 | ||
|DOI=10.1177/20417314211028574 | |DOI=10.1177/20417314211028574 | ||
|accessdate=2025-06-13 | |accessdate=2025-06-13 | ||
| + | }} | ||
| + | * {{REFweb | ||
| + | |url=https://www.hegemonmedia.com/p/survey-data-shows-the-foreskin-regeneration | ||
| + | |title=Survey Data Shows The Foreskin Regeneration Market Is Over 200 Billion Dollars | ||
| + | |last=Marotta | ||
| + | |first=Brendon | ||
| + | |init= | ||
| + | |author-link=Brendon Marotta | ||
| + | |publisher=Hegemon Media | ||
| + | |date=2023-06-28 | ||
| + | |accessdate=2025-06-18 | ||
}} | }} | ||
{{REF}} | {{REF}} | ||
Latest revision as of 11:23, 18 June 2025
Αkroprint is a newly formed tissue engineering company based in Chicago, Illinois, USA. The website states that it is a (for profit) C Corporation incorporated in Delaware.
Certain members of senior management were previously associated with Foregen.
Αkroprint has announced its intent to use "3D bioprinting technologies" to develop a tissue engineered replacement foreskin for circumcised men.[1]
In the logo, the company writes its name as αkroprint.
See also
External links
Official website. Retrieved 12 June 2025
Weng T, Zhang W, Xia Y, et al. 3D bioprinting for skin tissue engineering: Current status and perspectives. J Tissue Eng. 13 July 2021; 12: [20417314211028574]. PMID. PMC. DOI. Retrieved 13 June 2025.- Marotta, Brendon (28 June 2023).
Survey Data Shows The Foreskin Regeneration Market Is Over 200 Billion Dollars
, Hegemon Media. Retrieved 18 June 2025.
References
- ↑ Anonymous.
About Akroprint
, Akroprint. Retrieved 12 June 2025.